GC Wellbeing, a health/functional food manufacturer, said it signed a new export business agreement with YooYoung Pharmaceutical to enter the Chinese filler market.Under the accord, the two companies aim to develop, produce, market, and sell products specifically for the Chinese filler market, with
SK biopharmaceuticals announced its 2023 fourth quarter and annual financial results, highlighting significant revenue growth and a reduction in operating losses, thanks to increased sales of its epilepsy drug, cenobamate, and cost efficiency measures.The company's revenue for 2023 was 354.9 billion
Lunit, a medical AI company, said it has recorded its first sales in the U.S., just two months after obtaining approval from the U.S. FDA for Lunit INSIGHT DBT, its 3D breast cancer detection artificial intelligence (AI) solution, in November 2023.The company stressed that this achievement marks a s
An increasing number of Korean healthcare firms have been designated unfaithful disclosure companies or are at risk of receiving a similar notice.The Kosdaq Market Headquarters designates companies that fail to fulfill their disclosure obligations as mandated by related regulations as unfaithful dis
Genexine said it has completed the biologics license application (BLA) to the Ministry of Food and Drug Safety (MFDS) for Efesa (efepoetin alfa), its anemia treatment.Developed in collaboration with Kalbe through their joint venture, KGBio, Efesa is a third-generation treatment for renal anemia.Unli
Huons said Friday that it has signed a memorandum of understanding on strategic material supply with MFC to develop new drugs.Under the MOU, Huons will receive high-quality raw materials for new drug development from MFC, including key pharmaceutical ingredients such as Ilaprazole, Gemigliptin, Vare
Gilead Sciences said it has designated Yonsei Cancer Center as a Gilead HOPE (Hematology-Oncology Portfolio Engagement Site) institution and announced signing a memorandum of understanding (MoU) for collaborative research and development of innovative cancer therapeutics.Both organizations plan to w
Theragen Health, a subsidiary of Lotte Healthcare, said it has recently opened a new microbiome lab in Pankyo in Seongnam, Gyeonggi Province, significantly expanding its capabilities in the field of microbial analysis.The laboratory is equipped to handle up to 100,000 DNA samples annually.The microb
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have manufactured a novel bio-scaffold that exhibits electrical signals when pressure is applied, accelerating bone regeneration.Bone healing is complex, and conventional methods like bone grafting and growth factor delive
The Korean Health Industry Development Institute (KHIDI) said it has started accepting applications from Korean healthcare companies that want to move into its Boston Connect and Development (C&D) Incubation Office, located within the Cambridge Innovation Center (CIC) in Boston, Mass. KHIDI will acc
Researchers at the Korea Research Institute of Bioscience & Biotechnology (KRIBB) have successfully developed a gene therapy for hereditary spastic paraplegia (HSP), a rare, incurable disorder.HSP, a genetic neurological condition, leads to progressive stiffness and weakness in the legs, eventually
As the healthcare investment landscape undergoes rapid transformation in 2024, industry experts highlight emerging trends and strategic approaches to capitalizing on these changes.The focus is particularly on the increasing prominence of GLP-1 drugs in obesity treatment, significant mergers and acqu
Boehringer Ingelheim Korea said it has appointed Ana-Maria Boie as the new general manager (GM) and head of human pharma, effective from Jan. 15.According to the company, Ana-Maria Boie, the newly appointed GM, has worked in the pharmaceutical industry for 24 years and has amassed expertise in manag
Seegene announced a strategic collaboration with Microsoft to advance molecular diagnostics solutions to better diagnose and treat diseases.Under the accord, Seegene and Microsoft's Global Healthcare Team will jointly participate in annual symposiums for technology-sharing, connect with current and
Korean medical device firms have been actively engaging in mergers and acquisitions (M&A) since the start of the year, aiming to maximize synergies and create new growth drivers.Notably, these companies are adopting diverse strategies, including acquiring businesses outside their primary sectors, in
Dong-A ST said it has partnered with the Korea Institute of Science and Technology (KIST) to develop a novel treatment for inflammatory bowel disease (IBD).Under the accord, Dong-A ST will acquire the patent rights for the oral nucleic acid therapy delivery technology developed by KIST's Biomedical
Severance Hospital has developed an artificial intelligence (AI) model capable of rapidly and accurately diagnosing sepsis and predicting patient outcomes.Sepsis, a critical condition resulting from an abnormal body response to infection leading to major organ dysfunction, has high incidence and mor
AriBio, primarily known for its work to develop an oral Alzheimer's disease treatment candidate, has been penalized for the sale of cosmetics containing ingredients that are not permitted for use.The Ministry of Food and Drug Safety issued the penalty last Thursday, mandating a three-month suspensio
Samsung Bioepis, a subsidiary of Samsung Biologics, said it has received product approval from the Ministry of Food and Drug Safety for Epiruscly, a biosimilar referencing Soliris, last Friday.Soliris, developed by AstraZeneca's subsidiary Alexion Pharmaceuticals, is a high-cost biopharmaceutical fo
A research team at the Korea Institute of Science and Technology (KIST), in partnership with Seoul National University (SNU) and Kyung Hee University, developed a new drug delivery system that could better treat retinal diseases.Retinal diseases, such as age-related macular degeneration and retiniti